Published in Arteriosclerosis on December 31, 1985
Isolation of the thrombospondin membrane receptor. J Clin Invest (1987) 2.87
Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol (1989) 2.24
The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Mol Cell Biol (1991) 2.11
Two distinct cell-binding domains in laminin can independently promote nonneuronal cell adhesion and spreading. J Cell Biol (1987) 1.92
Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol (1988) 1.73
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest (1989) 1.33
Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci U S A (1989) 1.25
Fibronectin-binding protein of Streptococcus equi subsp. zooepidemicus. Infect Immun (1996) 1.18
Selective interaction of peripheral and central nervous system cells with two distinct cell-binding domains of fibronectin. J Cell Biol (1987) 1.13
Human osteosarcoma cells resistant to detachment by an Arg-Gly-Asp-containing peptide overproduce the fibronectin receptor. J Cell Biol (1987) 1.10
Taenia solium oncosphere adhesion to intestinal epithelial and Chinese hamster ovary cells in vitro. Infect Immun (2007) 0.97
Herpes simplex virus inhibits endothelial cell attachment and migration to extracellular matrix proteins. Am J Pathol (1989) 0.90
RGD-containing peptides inhibit the synthesis of myelin-like membrane by cultured oligodendrocytes. J Cell Biol (1988) 0.90
The platelet glycoprotein IIb/IIIa-like protein in human endothelial cells promotes adhesion but not initial attachment to extracellular matrix. J Cell Biol (1987) 0.89
Evidence that an RGD-dependent receptor mediates the binding of oligodendrocytes to a novel ligand in a glial-derived matrix. J Cell Biol (1988) 0.79
A defective cell surface collagen-binding protein in dermatosparactic sheep fibroblasts. J Cell Biol (1988) 0.77
Standardization of a fluorescent-based quantitative adhesion assay to study attachment of Taenia solium oncosphere to epithelial cells in vitro. J Immunol Methods (2011) 0.75
New perspectives in cell adhesion: RGD and integrins. Science (1987) 18.41
Integrin signaling. Science (1999) 16.44
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature (1984) 14.25
Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer (1977) 11.99
Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell (1985) 8.55
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (1998) 8.11
Arg-Gly-Asp: a versatile cell recognition signal. Cell (1986) 7.89
Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol (1996) 5.62
Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors. Science (1986) 5.58
Integrins and anoikis. Curr Opin Cell Biol (1997) 5.38
Organ targeting in vivo using phage display peptide libraries. Nature (1996) 5.20
Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell (1990) 5.15
Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A (1984) 5.13
Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature (1990) 4.90
Fibronectin: current concepts of its structure and functions. Coll Relat Res (1981) 4.82
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (1990) 4.64
Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest (1992) 4.49
Fibronectin: purification, immunochemical properties, and biological activities. Methods Enzymol (1982) 4.45
A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci U S A (1985) 4.44
Amino acid sequence of the human fibronectin receptor. J Cell Biol (1987) 4.08
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (1992) 3.96
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92
Interaction of soluble fibroblast surface antigen with fribrinogen and fibrin. J Exp Med (1975) 3.91
Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol (1997) 3.89
Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med (1999) 3.72
Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Cell (1981) 3.64
Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med (1978) 3.46
Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus. Int J Cancer (1974) 3.24
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res (2000) 3.24
Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci U S A (1983) 3.23
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A (1993) 3.16
Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci U S A (1986) 3.16
The human laminin receptor is a member of the integrin family of cell adhesion receptors. Science (1988) 3.03
Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci U S A (1983) 2.97
Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol Cell Biol (1996) 2.94
The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A (1995) 2.90
Multiple domains of the large fibroblast proteoglycan, versican. EMBO J (1989) 2.86
Distribution of fibroblast surface antigen in the developing chick embryo. J Exp Med (1975) 2.85
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Regulation of the fibronectin receptor affinity by divalent cations. J Biol Chem (1988) 2.78
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J (1985) 2.69
Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol (1981) 2.65
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest (1998) 2.65
The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci U S A (1985) 2.64
Distribution of fibroblast surface antigen: association with fibrillar structures of normal cells and loss upon viral transformation. J Exp Med (1974) 2.62
Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem (1987) 2.62
Basement membrane glycoprotein laminin binds to heparin. FEBS Lett (1980) 2.60
A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1). J Biol Chem (1990) 2.58
Laminin promotes neuritic regeneration from cultured peripheral and central neurons. J Cell Biol (1983) 2.58
cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci U S A (1986) 2.58
Association of insulin receptor substrate-1 with integrins. Science (1994) 2.56
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
Integrin activation by R-ras. Cell (1996) 2.50
Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology (N Y) (1995) 2.45
Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J (1997) 2.40
Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science (1996) 2.38
Superfibronectin is a functionally distinct form of fibronectin. Nature (1994) 2.38
Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J Biol Chem (1993) 2.37
Novel human serum protein from fibroblast plasma membrane. Nature (1974) 2.35
Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol (1999) 2.34
Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor. J Cell Biol (1989) 2.31
Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. J Biol Chem (1987) 2.29
Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site. J Cell Biol (1986) 2.29
Activation of protein kinase C precedes alpha 5 beta 1 integrin-mediated cell spreading on fibronectin. J Biol Chem (1993) 2.27
Cell surface distribution of fibronectin and vitronectin receptors depends on substrate composition and extracellular matrix accumulation. J Cell Biol (1988) 2.26
Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol (1985) 2.26
Alpha-fetoprotein: immunochemical purification and chemical properties. Expression in normal state and in malignant and non-malignant liver disease. Transplant Rev (1974) 2.26
Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol (1987) 2.25
Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res (1981) 2.21
Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A (1992) 2.18
Tyrosine phosphorylation of p130Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J Biol Chem (1995) 2.17
alpha-Fetoprotein in cancer and fetal development. Adv Cancer Res (1979) 2.16
Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry (1999) 2.10
Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA. Proc Natl Acad Sci U S A (1985) 2.08
The alpha v beta 1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin. J Cell Biol (1993) 2.06
A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence. J Cell Biol (1987) 2.04